Delivery Order SPE2DB22D3301-SPE2DB25FZ0QB
Award Date 9/5/25
Potential Completion Date 9/26/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for GAMUNEX-C 5 gram/50 milliliter vials totaling $1,214.68 under a firm fixed price contract. The delivery order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded to the vendor based on its demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,937.12 to AmerisourceBergen Drug Corp for GAMUNEX-C 1 gram/10 milliliter vials on October 8, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction for a specialized immunoglobulin product, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $111,324.90 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials on September 29, 2025. This firm fixed price delivery order is scheduled for completion by October 21, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a $14,161.68 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials. The order is scheduled for completion by September 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a continuation of the company's pharmaceutical supply services to federal military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,743.66 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 milliliter vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the delivery of an immunoglobulin...
- The Defense Logistics Agency awarded a $7,080.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials with a completion date of August 28, 2025. This non-set-aside award was issued on August 7, 2025, and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 mL vials on August 15, 2025, with completion expected by September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract is a firm fixed price delivery order with a ceiling value of $224,205.12 and an ultimate completion date of September 30, 2025. This award was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $28,323.36 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...